deltatrials

Metastatic colorectal cancer Trials in Pisa, Italy

Conditions / Metastatic colorectal cancer / Pisa, Italy

Clinical trials for Metastatic colorectal cancer investigate a range of treatment strategies and patient populations.

26 total trials for this combination

Showing top 10 of 26 trials

Trials

NCT ID Title Status Phase
NCT05330429 Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) TERMINATED PHASE2
NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation RECRUITING
NCT05217446 A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT04322539 A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer COMPLETED PHASE3
NCT03306394 A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic). COMPLETED PHASE3
NCT06792695 A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer RECRUITING PHASE2
NCT01767857 A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer TERMINATED PHASE3
NCT03869892 Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. ACTIVE_NOT_RECRUITING PHASE3
NCT01103323 Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy COMPLETED PHASE3
NCT04793958 Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) ACTIVE_NOT_RECRUITING

Related Pages